Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.7K
Cancer Therapies02:49

Cancer Therapies

9.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

5.4K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.4K
Gene Therapy00:59

Gene Therapy

27.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.4K
Group Therapy01:26

Group Therapy

379
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
379

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Health literacy-sensitive self-management interventions for chronic obstructive pulmonary disease: a systematic review and meta-analysis.

NPJ primary care respiratory medicine·2026
Same author

Hardware-Attentive Programmable Fourier Ptychography Enables Task-Adaptive Label-Free Virtual Staining.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Bacterial phospholipid selective quaternary phosphonium polymers with potent antibacterial activity.

Materials today. Bio·2026
Same author

Diniconazole leads to neurotoxicity in zebrafish via triggering TLR4/MyD88-mediated immune-inflammatory responses.

Fish & shellfish immunology·2026
Same author

NIR-VIS multispectral fused imaging with extended depth-of-field for high-throughput virtual staining.

Optics letters·2026
Same author

GCRV-I capsid protein VP5 induces TRAP1 degradation via K48-linked ubiquitination for immune evasion and viral proliferation.

Fish & shellfish immunology·2026

Related Experiment Video

Updated: Jan 22, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.5K

Targeting mTOR for cancer therapy.

Hui Hua1, Qingbin Kong2, Hongying Zhang2

  • 1State Key Laboratory of Biotherapy, Laboratory of Stem Cell Biology, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, 610041, China.

Journal of Hematology & Oncology
|July 7, 2019
PubMed
Summary

Mechanistic target of rapamycin (mTOR) signaling regulates cell growth and is crucial in cancer. This review covers mTOR inhibitors for cancer therapy and discusses resistance mechanisms.

Keywords:
CancerDrug resistanceOncogeneTargeted therapymTOR

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.8K
A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction
05:28

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

17.6K

Related Experiment Videos

Last Updated: Jan 22, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.5K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.8K
A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction
05:28

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

17.6K

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Mechanistic target of rapamycin (mTOR) is a key protein kinase regulating fundamental cellular processes like growth, metabolism, and immunity.
  • mTOR functions within complexes (mTORC1/2) and phosphorylates numerous targets, influencing protein synthesis, nutrient metabolism, and growth factor signaling.
  • Aberrant mTOR activation is implicated in promoting tumor growth and metastasis, making it a significant target in cancer research.

Purpose of the Study:

  • To provide an updated review of recent advances in understanding mTOR signaling pathways.
  • To summarize the development of mTOR inhibitors for cancer therapy.
  • To discuss the mechanisms of resistance to mTOR inhibitors in cancer cells.

Main Methods:

  • Literature review of recent scientific publications on mTOR signaling and cancer therapy.
  • Analysis of the roles of mTOR complexes and their targets in cellular regulation.
  • Synthesis of information on approved and investigational mTOR inhibitors.

Main Results:

  • mTOR signaling is critical for cell growth, survival, metabolism, and immunity, with dysregulation driving cancer progression.
  • Numerous mTOR inhibitors have been developed, with some approved for clinical use, while others are in ongoing trials.
  • Understanding resistance mechanisms is crucial for optimizing mTOR-targeted cancer therapies.

Conclusions:

  • mTOR signaling is a vital regulator of cellular functions and a significant driver of cancer.
  • mTOR inhibitors represent a promising therapeutic strategy for various cancers.
  • Further research into resistance mechanisms is essential for improving the efficacy of mTOR-targeted treatments.